Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.357
+0.004 (1.05%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Theriva Biologics Employees
As of December 31, 2025, Theriva Biologics had 16 total employees, including 15 full-time and 1 part-time employees. The number of employees decreased by 6 or -27.27% compared to the previous year.
Employees
16
Change (1Y)
-6
Growth (1Y)
-27.27%
Revenue / Employee
n/a
Profits / Employee
-$1,578,063
Market Cap
16.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Citius Pharmaceuticals | 23 |
| IN8bio | 17 |
| SeaStar Medical Holding | 17 |
| NewcelX | 15 |
| Soligenix | 14 |
| Genenta Science | 9 |
| Pasithea Therapeutics | 5 |
| Cadrenal Therapeutics | 4 |
TOVX News
- 8 days ago - Why Is Theriva Stock Gaining Monday? - Benzinga
- 11 days ago - Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting - GlobeNewsWire
- 4 months ago - Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) - GlobeNewsWire
- 6 months ago - Theriva Biologics Provides Response to Unusual Market Action - GlobeNewsWire
- 6 months ago - Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds - GlobeNewsWire
- 7 months ago - Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) - GlobeNewsWire
- 9 months ago - Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire
- 1 year ago - Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results - GlobeNewsWire